Variant Summary
- Also known as
- EML4-ALK E20-E20
- HGVS
- —
- Variant Type(s)
- transcript_fusion
- Evidence Items
- 3
Evidence Level Distribution
Level C: 1Level D: 2
Evidence Items
Showing CIViC evidence rows where gene = EML4::ALK and variant = e20::e20.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| C | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Crizotinib | 2 |
| D | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Crizotinib | 2 |
| D | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Crizotinib,Alvespimycin | 2 |